SkyePharma develops pharmaceutical products, which benefit from drug delivery technologies that provide easier-to-use and more effective medicines. SkyePharma has FDA and EMEA approved manufacturing facilities. SkyePharma’s proprietary injectable technology is the DepoFoam system that provides controlled drug delivery for an extended period of time, as seen in oncological product, DepoCyt, and pain management products, DepoMorphine and DepoBupivacaine.